Emily Tamadonfar, MD
University of Southern California Keck School of Medicine Los Angeles, California
Katherine Wong, MD
University of Southern California Keck School of Medicine Los Angeles, California
Mya Schiess, MD
University of Texas Health Science Center Houston, Texas
Emily Taraneh Tamadonfar is an assistant professor of neurology specializing in movement disorders at the University of Southern California. Her research interests include neuroimaging biomarkers in Parkinson’ s disease, the development of advanced algorithms in diagnosis and disease prognostication, and drug development in parkinsonian syndromes and dystonia. She serves as a site primary investigator and sub-investigator in several clinical treatment trials for Parkinson’ s disease, essential tremor and dystonia. Additionally, Dr. Tamadonfar has a special interest and training in medical education research and curriculum development. She serves as the movement disorders fellowship co-director at the University of Southern California.
Katherine Wong is an assistant professor of clinical neurology and a board-certified neurologist specializing in movement disorders and behavioral neurology at the Keck School of Medicine of the University of Southern California. She completed her neurology residency and movement disorders fellowship at University of California San Francisco. Dr. Wong is interested in Parkinson’ s disease clinical trials, the contribution of the blood brain barrier and the gut microbiome to Parkinson’ s disease clinical symptoms, the overlap of memory and movement disorders, and increasing access to specialty care and clinical trials for a diverse population of patients.
Mya Schiess is a professor and the Adriana Blood Distinguished Chair in Neurology at McGovern Medical School at The University of Texas Health Science Center at Houston, as well as the director of the UTHealth Movement Disorders and Neurodegenerative Diseases Clinic and Fellowship Training Program( UTMOVE). Since 2001, Dr. Schiess has supervised and mentored over 39 movement disorders fellows, over half of whom hold clinical-scientist or clinical-educator academic positions. For over 20 years, Dr. Schiess has led clinical and translational research in regenerative neurology with stem cell therapies for Parkinsonian syndromes and neuromodulation with deep brain stimulation.
Fall 2025 19